The U.S. turkey industry continues to be hampered by a lack of approved efficacious drugs, according to a 2017 survey. Since 2005, four medications have been withdrawn, leaving the industry without any recourse to treat colibacillosis, blackhead and other diseases. As he has done annually for over 17 years, Steven Clark, DVM, Devenish Nutrition, conducted the survey, which represents 99.9 percent of the turkey industry. Read more
Trackback from your site.